Brief: Double Bond Pharmaceutical: Si-Studio divests 400,000 B-shares
19/11/2018 07:23
Nov 19 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL
AB DBPHAb.TE :
* SAID ON FRIDAY SI-STUDIO DIVESTED 400,000 CLASS B SHARES
IN CO
IN ORDER TO REPAY A SECURITIES CREDIT
Source text for Eikon: urn:newsml:reuters.com:*:nWkr29X3t3
Further company coverage: DBPHAb.TE
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University